Kerman University of Medical Sciences

Simorgh Research Repository
Not a member yet
    16687 research outputs found

    Looking into a Deluded Brain through a Neuroimaging Lens

    No full text
    Delusions are irrational, tenacious, and incorrigible false beliefs that are the most common symptom of a range of brain disorders including schizophrenia, Alzheimer�s, and Parkinson�s disease. In the case of schizophrenia and other primary delusional disorders, their appearance is often how the disorder is first detected and can be sufficient for diagnosis. At this time, not much is known about the brain dysfunctions leading to delusions, and hindering our understanding is that the complexity of the nature of delusions, and their very unique relevance to the human experience has hampered elucidation of their underlying neurobiology using either patients or animal models. Advances in neuroimaging along with improved psychiatric and cognitive modeling offers us a new opportunity to look with more investigative power into the deluded brain. In this article, based on data obtained from neuroimaging studies, we have attempted to draw a picture of the neural networks involved when delusion is present and evaluate whether different manifestations of delusions engage different regions of the brain. © The Author(s) 2020

    Bombay in the early Nineteenth Century: From the (Almost) lost diaries of Abdul Latif Shushtari

    No full text
    The presence of a curious Iranian in Bombay in 1801�1804 resulted in an unpublished extensive diary, a record containing much valuable data about urban development and business relations in this harbour city. The author�s daily commentary and precise notes, compiled over the first 3 years of the nineteenth century, constitutes an unusual archive from colonial times, providing information about Bombay and its Parsis, as well as the role of Persians in the economy and politics of India under the East India Company (EIC). © 2021 SAGE Publications

    Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study

    No full text
    Introduction: Phase IV post-marketing surveillance studies are needed to evaluate the real-world safety and effectiveness of drug products. This study aimed to evaluate the safety and effectiveness of biosimilar etanercept (Altebrel, AryoGen Co., Iran) in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA). Methods: In this open-label, multicenter, prospective, observational, post-marketing surveillance study, 583 patients received biosimilar etanercept 25 mg twice weekly or 50 mg once weekly and were followed up to 12 months. The primary objective was to evaluate the safety of biosimilar etanercept by documenting all the adverse events in the case report forms throughout the study period. The secondary objective was to evaluate the effectiveness of biosimilar etanercept in study patients, where longitudinal changes in health assessment questionnaire (HAQ), pain, and disease activity scores were assessed. Results: A total of 583 patients (44.80 ± 13.09 years of age) were included and followed for an average of 8.12 ± 3.96 months. Among all patients, 172 (29.50) experienced at least one adverse event, and injection site reaction, abdominal pain, and upper respiratory tract infection were the most common. HAQ scores decreased from 1.32 ± 0.77 at baseline to 0.81 ± 0.61 at 12 months in patients with RA/PsA (p < 0.01) and from 0.82 ± 0.58 at baseline to 0.66 ± 0.63 at 12 months in patients with AS (p = 0.18). Pain scores decreased from 6.49 ± 2.41 at baseline to 3.51 ± 2.39 at 12 months (p < 0.01). Conclusion: The results demonstrated the real-world safety and effectiveness of biosimilar etanercept in patients with RA, PsA, and AS. Trial Registration: ClinicalTrials.gov identifier NCT04582084. © 2021, The Author(s), under exclusive licence to Springer Healthcare Ltd. part of Springer Nature

    Recent developments in polymer nanocomposite-based electrochemical sensors for detecting environmental pollutants

    No full text
    The human population is generally subjected to diverse pollutants and contaminants in the environment like those in the air, soil, foodstuffs, and drinking water. Therefore, the development of novel purification techniques and efficient detection devices for pollutants is an important challenge. To date, experts in the field have designed distinctive analytical procedures for the detection of pollutants including gas chromatography/mass spectrometry and atomic absorption spectroscopy. While the mentioned procedures enjoy high sensitivity, they suffer from being laborious, expensive, require advanced skills for operation, and are inconvenient to deploy as a result of their massive size. Therefore, in response to the above-mentioned limitations, electrochemical sensors are being developed that enjoy robustness, selectivity, sensitivity, and real-time measurements. Considerable advancements in nanomaterials-based electrochemical sensor platforms have helped to generate new technologies to ensure environmental and human safety. Recently, investigators have expanded considerable effort to utilize polymer nanocomposites for building the electrochemical sensors in view of their promising features such as very good electrocatalytic activities, higher electrical conductivity, and effective surface area in comparison to the traditional polymers. Herein, the first section of this review briefly discusses the most important methods for polymer nanocomposites synthesis, such as in situ polymerization, direct mixing of polymer and nanofillers (melt-mixing and solution-mixing), sol-gel, and electrochemical methods. It then summarizes the current utilization of polymer nanocomposites for the preparation of electrochemical sensors as a novel approach for monitoring and detecting environmental pollutants which include heavy metal ions, pesticides, phenolic compounds, nitroaromatic compounds, nitrite, and hydrazine in different mediums. Finally, the current challenges and future directions for the polymer nanocomposites-based electrochemical sensing of environmental pollutants are outlined. © 2021 American Chemical Societ

    Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects

    No full text
    Background: Pulmonary arterial hypertension (PAH) is a disastrous disease that current treatments cannot prevent its progression. The present study investigated the effects of perillyl alcohol (PA), a natural monoterpene, on the experimental PAH in male Wistar rats. Methods: Rats divided into eight groups of control, Monocrotaline (MCT), MCT+vehicle, and MCT+PA with doses of 20, 30, 40, 50, and 60 mg/kg. PAH was induced by a single injection of monocrotaline (60 mg/kg) on day 0. The animals in the groups of MCT+vehicle and MCT+PA received the vehicle or PA from day 22 to 42 once a day. On day 43, under general anesthesia, right ventricular systolic pressure (RVSP), as an index of pulmonary artery systolic pressure, and the ratio of the right ventricle to the left ventricle plus septum weight, as the right ventricular hypertrophy index (RVHI), were measured. Also, some histological and biochemical indices were assessed in the lung tissue. Results: MCT significantly (p < .001) enhanced the RVSP and RVHI compared to the control group (89.4 ± 8.2 vs 23 ± 3.3 mmHg & 0.63 ± 0.08 vs 0.26 ± 0.04 respectively). It also increased oxidative stress and inflammatory cytokines and reduced Bax/Bcl2 ratio. Treatment with PA significantly recovered RVSP and hypertrophy index and suppressed vascular cell proliferation, oxidant production, and inflammatory processes. Conclusion: PA exerted noticeable protective and curative effects against MCT-induced PAH and pulmonary vascular remodeling through inhibiting cellular proliferation, oxidative stress, and inflammation. Therefore, PA can be considered as a new therapeutic goal for the treatment of PAH. © 2020 Taylor & Francis

    Renoprotective effects of estrogen on acute kidney injury: the role of SIRT1

    No full text
    Acute kidney injury (AKI) is a common syndrome associated with high morbidity and mortality, despite progress in medical care. Many studies have shown that there are sex differences and different role of sex hormones particularly estrogens in kidney injury. In this regard, the incidence and rate of progression of kidney diseases are higher in men compared with women. These observations suggest that female sex hormone may be renoprotective. Silent information regulator 2 homolog 1 (SIRT1) is a histone deacetylase, which is implicated in multiple biologic processes in several organisms. In the kidneys, SIRT1 inhibits renal cell apoptosis, inflammation, and fibrosis. Studies have reported a link between SIRT1 and estrogen. In addition, SIRT1 regulates ERα expression and inhibition of SIRT1 activity suppresses ERα expression. This effect leads to inhibition of estrogen-responsive gene expression. In this text, we review the role of SIRT1 in mediating the protective effects of estrogen in the onset and progression of AKI. © 2021, The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature

    13,094

    full texts

    16,687

    metadata records
    Updated in last 30 days.
    Simorgh Research Repository
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇